Effectiveness of Antihypertensive Monotherapy and Combination Therapy in Managing Blood Pressure Among the Elderly
DOI:
https://doi.org/10.12982/BSCM.2026.52Keywords:
hypertension, eastern Indonesia, middle-aged, antihypertensive therapy, blood pressureAbstract
Objective To evaluate the effectiveness of monotherapy versus combination therapy in controlling blood pressure in the elderly population in eastern Indonesia, i.e., Central Sulawesi.
Methods This study used a cross-sectional design, examining secondary data from the medical records of inpatients with hypertension in a population in eastern Indonesia. The inclusion criteria included patients aged 45 years or older receiving antihypertensive therapy who had complete blood pressure data. Data were analyzed using R 4.3.2. Relationships between variables were tested using inferential analysis. A p-value < 0.05 was set as the statistical significance threshold.
Results Most patients were female (60.0%) and aged 45-59 years (40.0%). Nearly half (48.0%) had been diagnosed with uncomplicated hypertension, while 29.0% also had cardiovascular comorbidities. Patients received
either monotherapy or combination therapy, with calcium channel blockers (CCBs) being the most common drug class used. Blood pressure significantly decreased after therapy, with mean systolic pressure reduced from 162 to 135 mmHg and diastolic from 95 to 79 mmHg (p = 0.000). Combination therapy produced a slightly greater reduction than monotherapy, although the difference was not statistically significant. These findings suggest that both monotherapy and combination therapy can effectively reduce blood pressure in elderly patients, with combination therapy offering potential advantages. This study highlights the need for personalized treatment strategies that consider the age, comorbidities, and drug tolerance of all elderly patients based on hypertension therapy guidelines.
Conclusion Both combination and monotherapy treatment strategies are similarly effective in lowering blood pressure in elderly patients. Given
the presence of comorbidities and the risk of side effects, a personalized approach using combination therapy may offer an effective and safe option for managing hypertension in geriatric patients. These findings support more informed and tailored clinical decision-making in hospital care settings.
References
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–104.
Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16:223–37.
World Health Organization. Hypertension. Geneva: WHO; 2023 [cited 2025 May 15]. Available from: https://www.who.int/newsroom/fact-sheets/detail/hypertension
Tim Penyusun SKI. Survei Kesehatan Indonesia (SKI) 2023 dalam angka. Jakarta: Kementerian Kesehatan Republik Indonesia; 2024 [cited 2025 May 15]. Available from: https://www.badankebijakan.kemkes.go.id/ski-2023-dalam-angka/
Dinas Kesehatan Provinsi Sulawesi Tengah. Profil kesehatan Provinsi Sulawesi Tengah tahun 2023 [Internet]. Palu: Dinas Kesehatan Provinsi Sulawesi Tengah; 2024 [cited 2025 May 26]. Available from: https://dinkes.sultengprov.go.id/wp-content/uploads/2025/04/profil-kesehatan-2023.pdf [in Indonesian]
Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension. 2020;75:1334–57.
Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. Hypertension. 2018;71:e13–115.
National Institute for Health and Care Excellence. Hypertension in adults: diagnosis and management. NICE guideline NG136. London: NICE; 2019 [updated 2023 Nov 21] [cited 2026 June 5]. Available from: https://www.nice.org.uk/guidance/ng136
Wald DS, Law M, Morris JK, Bestwick JP, Wald NJ. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med. 2009;122:290–300.
Iorga A, Cunningham CM, Moazeni S, Ruffenach G, Umar S, Eghbali M. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol Sex Differ. 2017;8:33. PubMed PMID: 29065927
Mirabito Colafella KM, Denton KM. Sex-specific differences in hypertension and associated cardiovascular disease. Nat Rev Nephrol. 2018;14:185–201.
Motlani V, Motlani G, Pamnani S, Sahu A, Acharya N. Endocrine changes in postmenopausal women: a comprehensive view. Cureus. 2023;15:e51287. PubMed PMID: 38288203
World Health Organization. Ageing and health. Geneva: WHO; 2024 [cited 2025 May 20]. Available from: https://www.who.int/news-room/fact-sheets/detail/ageing-and-health
Herzog MJ, Müller P, Lechner K, Stiebler M, Arndt P, Kunz M, et al. Arterial stiffness and vascular aging: mechanisms, prevention, and therapy. Signal Transduct Target Ther. 2025;10:282. PubMed PMID: 40887468
Kim KI. Optimal target blood pressure in older patients with hypertension. Cardiovasc Prev Pharmacother. 2023;5:41–8.
Ji H, Kim A, Ebinger JE, Niiranen TJ, Claggett BL, Bairey Merz CN, et al. Sex differences in blood pressure trajectories over the life course. JAMA Cardiol. 2020;5:19–26.
Lip GYH, Coca A, Kahan T, Boriani G, Manolis AS, Olsen MH, et al. Hypertension and cardiac arrhythmias: a consensus document. Europace. 2017;19:891–911.
Libby P, Buring JE, Badimon L, Hansson GK, Deanfield J, Bittencourt MS, et al. Atherosclerosis. Nat Rev Dis Primers. 2019;5(1):56. PubMed PMID: 31420554
Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol. 2018;34:575–84.
Noviyanti F, Decroli E, Sastri S. Perbedaan kadar LDL-kolesterol pada pasien diabetes melitus tipe 2 dengan dan tanpa hipertensi di RS Dr. M. Djamil Padang Tahun 2011. J Kesehat Andalas. 2015;4:545-50.
Kementerian Kesehatan Republik Indonesia. Pedoman Nasional Pelayanan Kedokteran Tata Laksana Hipertensi Dewasa. Jakarta: Kemenkes RI; 2021 [cited 2025 May 20]. Available from: https://kemkes.go.id/id/pnpk-2021---tatalaksana-hipertensi-dewasa
Parati G, Kjeldsen S, Coca A, Cushman WC, Wang J. Adherence to single-pill versus free-equivalent combination therapy in hypertension: a systematic review and meta-analysis. Hypertension. 2021;77:692–705.
Burnier M, Egan BM. Adherence in hypertension: a review of prevalence, risk factors, impact, and management. Circ Res. 2019;124:1124–40.
DiPiro JT, Schwinghammer TL, Ellingrod VL, DiPiro CV. Pharmacotherapy handbook. 11th ed. New York: McGraw Hill; 2021.
Bakris GL, Sarafidis PA, Weir MR, Dahlöf B, Pitt B, Jamerson K, et al. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial. Lancet. 2010;375(9721):1173–81.
Kim-Mitsuyama S, Ogawa H, Matsui K, Jinnouchi T, Jinnouchi H, Arakawa K, et al. An angiotensin II receptor blocker–calcium channel blocker combination prevents cardiovascular events in elderly high-risk hypertensive patients with chronic kidney disease better than high-dose angiotensin II receptor blockade alone. Kidney Int. 2013;83:167–76.
James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence- based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507–20.
Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957–67.
Egan BM, Mattix-Kramer HJ, Basile JN, Sutherland SE. Managing hypertension in older adults. Curr Hypertens Rep. 2024;26:157–67.
Stamler J, Chan Q, Daviglus ML, Dyer AR, Van Horn L, Garside DB, et al. Relation of dietary sodium (salt) to blood pressure and its possible modulation by other dietary factors: the INTERMAP study. Hypertension. 2018;71:631–7.
